Novel glucitol derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes

Details for Australian Patent Application No. 2005265715 (hide)

Owner Chugai Seiyaku Kabushiki Kaisha

Inventors Lee, Sang-Hak; Sato, Tsutomu; Nishimoto, Masahiro; Sakaitani, Masahiro; Matsuoka, Hiroharu; Kato, Yasuharu

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005265715

PCT Pub. Number WO2006/011502

Priority 2004-218895 27.07.04 JP; 2004-343942 29.11.04 JP

Filing date 27 July 2005

Wipo publication date 2 February 2006

International Classifications

C07D 409/10 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

A61K 31/381 (2006.01) - having five-membered rings

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

8 February 2007 PCT application entered the National Phase

  PCT publication WO2006/011502 Priority application(s): WO2006/011502

23 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005265769-5-substituted-2-phenylamino-benzamid es as MEK inhibitors

2005265697-Buried pipe examining method